PGRMC1

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, PGRMC1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated PGRMC1 data layer compared with 24 for mass-spec protein and 8 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher PGRMC1 Mutation is associated with better disease-free survival. In most high-consensus cancer types, elevated PGRMC1 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

UCEC are the cancer types where PGRMC1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UCECDFSMedianAll1.0000.830.0256view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

PGRMC1–UCEC (DFS)

Kaplan–Meier survival curve for PGRMC1 mutant vs wild-type samples in UCEC.

Open the UCEC breakdown →

Exploration